Scarica l'app Stockscreener
1.29
3.01%
-0.04
Dopo l'orario di chiusura:
1.31
0.02
+1.55%
Precedente Chiudi:
$1.33
Aprire:
$1.28
Volume 24 ore:
1.19M
Relative Volume:
0.64
Capitalizzazione di mercato:
$91.73M
Reddito:
$391.70K
Utile/perdita netta:
$-52.34M
Rapporto P/E:
-1.72
EPS:
-0.75
Flusso di cassa netto:
$-45.92M
1 W Prestazione:
+3.20%
1M Prestazione:
+159.82%
6M Prestazione:
+152.94%
1 anno Prestazione:
+18.35%
Intervallo 1D:
$1.27
$1.34
Intervallo di 1 settimana:
$1.16
$1.34
Portata 52W:
$0.2425
$1.47
Ovid Therapeutics Inc Stock (OVID) Company Profile
Nome
Ovid Therapeutics Inc
Settore
Industria
Telefono
212-776-4381
Indirizzo
441 NINTH AVENUE, 14TH FLOOR, NEW YORK, NY
Confronta OVID con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
OVID
Ovid Therapeutics Inc
|
1.29 | 87.46M | 391.70K | -52.34M | -45.92M | -0.75 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Ovid Therapeutics Inc Stock (OVID) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-08 | Ripresa | B. Riley Securities | Buy |
| 2024-06-18 | Downgrade | Oppenheimer | Outperform → Perform |
| 2024-04-30 | Iniziato | B. Riley Securities | Buy |
| 2024-04-29 | Iniziato | H.C. Wainwright | Buy |
| 2024-04-05 | Iniziato | Wedbush | Outperform |
| 2023-12-21 | Iniziato | BTIG Research | Buy |
| 2023-10-13 | Iniziato | Oppenheimer | Outperform |
| 2021-04-20 | Downgrade | Cantor Fitzgerald | Buy → Neutral |
| 2021-03-03 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2020-12-02 | Downgrade | Citigroup | Buy → Neutral |
| 2020-12-02 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| 2019-09-04 | Iniziato | RBC Capital Mkts | Outperform |
| 2018-04-20 | Iniziato | Ladenburg Thalmann | Buy |
Mostra tutto
Ovid Therapeutics Inc Borsa (OVID) Ultime notizie
What hedge funds are buying Ovid Therapeutics Inc.Weekly Profit Summary & High Accuracy Investment Signals - khodrobank.com
Smart tools for monitoring Ovid Therapeutics Inc.’s price action2025 Historical Comparison & Reliable Price Breakout Signals - Newser
Can swing trading help recover from Ovid Therapeutics Inc. losses2025 Biggest Moves & Smart Money Movement Tracker - Newser
Multi asset correlation models including Ovid Therapeutics Inc.Profit Target & AI Based Trade Execution Alerts - Newser
Visualizing Ovid Therapeutics Inc. stock with heatmapsJuly 2025 Final Week & Pattern Based Trade Signal System - Newser
What indicators show strength in Ovid Therapeutics Inc.July 2025 Trade Ideas & Free Real-Time Market Sentiment Alerts - Newser
Real time social sentiment graph for Ovid Therapeutics Inc.Trade Risk Assessment & Low Drawdown Investment Ideas - Newser
Custom watchlist performance reports with Ovid Therapeutics Inc.Weekly Market Report & Expert Curated Trade Setup Alerts - Newser
Is Ovid Therapeutics Inc. forming a bottoming base2025 Short Interest & Reliable Momentum Entry Alerts - Newser
What MACD signals say about Ovid Therapeutics Inc.Product Launch & Safe Entry Point Alerts - Newser
Using Bollinger Bands to evaluate Ovid Therapeutics Inc.2025 Big Picture & Free High Return Stock Watch Alerts - Newser
Full technical analysis of Ovid Therapeutics Inc. stockJuly 2025 Patterns & Precise Swing Trade Entry Alerts - Newser
What recovery options are there for Ovid Therapeutics Inc.Sell Signal & Weekly Return Optimization Plans - Newser
Multi factor analysis applied to Ovid Therapeutics Inc.Market Risk Analysis & Stock Portfolio Risk Management - Newser
Ovid Therapeutics Reports Increased Revenue Amid Challenges - MSN
Investment Review: Is Ovid Therapeutics Inc. forming a breakout patternJuly 2025 Update & Free Risk Controlled Daily Trade Plans - khodrobank.com
How hedge fund analytics apply to Ovid Therapeutics Inc. stockSwing Trade & Community Verified Trade Alerts - Newser
Why is Ovid Therapeutics Inc. stock going upPortfolio Value Report & Daily Chart Pattern Signal Reports - khodrobank.com
Is Ovid Therapeutics Inc. subject to activist investor interestJuly 2025 Drop Watch & Safe Investment Capital Preservation Plans - khodrobank.com
Is it too late to sell Ovid Therapeutics Inc.Weekly Trading Summary & Stock Portfolio Risk Management - Newser
Ovid Therapeutics Inc. stock volume spike explainedTrade Risk Summary & Daily Stock Trend Watchlist - Newser
Analyzing Ovid Therapeutics Inc. with multi timeframe chartsWeekly Profit Analysis & AI Forecasted Stock Moves - Newser
Using Ichimoku Cloud for Ovid Therapeutics Inc. technicalsMarket Movement Recap & Entry Point Confirmation Signals - Newser
Does Ovid Therapeutics Inc. fit your quant trading modelWeekly Loss Report & Fast Moving Trade Plans - Newser
Quantitative breakdown of Ovid Therapeutics Inc. recent moveRate Cut & Weekly High Potential Stock Alerts - Newser
Ovid Therapeutics Inc. recovery potential after sell offTrade Exit Summary & Weekly High Return Forecasts - Newser
Traders Consider Averaging Down in Ovid Therapeutics Inc. getLinesFromResByArray error: size == 0 - kangso.co.kr
What machine learning models say about Ovid Therapeutics Inc.Weekly Trade Summary & Real-Time Sentiment Analysis - Newser
Using R and stats models for Ovid Therapeutics Inc. forecastingMarket Risk Analysis & Real-Time Stock Entry Alerts - Newser
Ovid Therapeutics Inc. Company Revenue and Profit Trends: A Deep Dive2025 Historical Comparison & AI Driven Stock Movement Reports - Newser
Ovid Therapeutics Inc Azioni (OVID) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Ovid Therapeutics Inc Azioni (OVID) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Rona Jeffrey A | CBFO |
Feb 26 '25 |
Sale |
0.56 |
3,902 |
2,185 |
67,973 |
| ALEXANDER MARGARET A. | President and COO |
Jan 27 '25 |
Buy |
0.73 |
6,810 |
4,971 |
34,935 |
1.75%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):